Укр Eng
Press center

Publications

SAFEMed continues to strength regulatory framework for improved prescribing and dispensing of prescription medicines and medical devices
News Projects

Falsified medicines in Ukraine as a principle of impunity or why the courts cannot prosecute

Criminal responsibility for the falsification of medicines. - Oleksandr Tsurkan, Interfax-Ukraine, 21.02.2023

Legalization of electronic money: the changes the Law No. 2888-IX introduces

Changes to the order of circulation of electronic money, and how they will affect the participants of this type of payments. - Angelina Furman, LIGA:ZAKON BUSINESS, 21.02.2023

Reservation of conscripts: new rules and the algorithm of actions

Key innovations of the Resolution No. 76 of the CMU, which entered into force on January 31, 2023 - Angelina Furman, LIGA:ZAKON BUSINESS, 02.07.2023

The state and business: transformation of relations

On December 6, 2022, the 12th Pharmacy Summit of Ukraine-2022 took place in Kyiv. Dmytro Aleshko, managing partner of Legal Alliance, presented an overview of legislative innovations

Reputation management in wartime

Reputation parameters for various target groups and management algorithms for businesses. - Angelina Furman, LIGA:ZAKON BUSINESS, 02.11.2022

The new law on joint-stock companies: what did the Verkhovna Rada adopt?

The most important novelties influencing business functioning of joint-stock companies. - Anna Tymoshenko, LIGA:ZAKON BUSINESS, 14.10.2022

Trade secrets: protection tools and liability for disclosure

Some aspects of protection of commercial secrets and actions of the company in relation to employees. - Yana Verhun, Daria Gulevska, LIGA:ZAKON BUSINESS, 28.09.2022

Innovations in the field of intellectual property and medicine advertising: what does the new Law of Ukraine "On Medicinal Products" envisage?

On September 6-7, Legal Alliance law firm held a webinar dedicated to the new version of the Law of Ukraine "On Medicinal Products". Innovations in the field of intellectual property, in particular in the area of data exclusivity for the registration dossier, issues of parallel import, production, advertising and promotion of medicines were in focus.

Get information about current events

By clicking the button, you consent to the processing of personal data